CWBHF - Charlotte's Web Holdings, Inc.
OTC
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
Louisville,
United States
Type: Equity
CWBHF price evolution
CWBHF
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $47.82 | $51.02 | $61.73 | $60.78 |
| Short term investments | $1.17 | |||
| Net receivables | $2.33 | $2.49 | $2.48 | $6.84 |
| Inventory | $21.54 | $22.63 | $23.76 | $25.57 |
| Total current assets | $78.17 | $83.74 | $94.86 | $101.14 |
| Long term investments | $11 | $11.1 | $10.7 | $0.71 |
| Property, plant & equipment | $42.11 | $43.12 | $42.15 | $43.99 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $152.55 | $163.87 | $176.59 | $175.97 |
| Current liabilities | ||||
| Accounts payable | $2.86 | $3.58 | $3.19 | $3.71 |
| Deferred revenue | ||||
| Short long term debt | $2.25 | $2.25 | $2.25 | $2.27 |
| Total current liabilities | $23.65 | $24.78 | $22.61 | $22.62 |
| Long term debt | $42.53 | $40.39 | $40.31 | $38.43 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $96.99 | $100.13 | $98.23 | $101.07 |
| Shareholders' equity | ||||
| Retained earnings | -$271.72 | -$263.14 | -$248 | -$250.84 |
| Other shareholder equity | ||||
| Total shareholder equity | $55.56 | $63.74 | $78.36 | $74.9 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $47.82 | $66.96 | $19.49 | $52.8 |
| Short term investments | $1.17 | $2.31 | $0.93 | $2.74 |
| Net receivables | $2.33 | $2.42 | $17.09 | $20.47 |
| Inventory | $21.54 | $26.95 | $52.08 | $63.16 |
| Total current assets | $78.17 | $103.76 | $95.81 | $143.79 |
| Long term investments | $11 | |||
| Property, plant & equipment | $42.11 | $45.85 | $56.76 | $60.4 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $152.55 | $187.64 | $171.51 | $310.79 |
| Current liabilities | ||||
| Accounts payable | $2.86 | $4.02 | $5.05 | $4.89 |
| Deferred revenue | ||||
| Short long term debt | $2.25 | $2.31 | $2.1 | |
| Total current liabilities | $23.65 | $21.43 | $20.17 | $28.87 |
| Long term debt | $42.53 | $37.42 | ||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $96.99 | $110.14 | $41.07 | $56.55 |
| Shareholders' equity | ||||
| Retained earnings | -$271.72 | -$247.93 | -$188.61 | -$50.89 |
| Other shareholder equity | ||||
| Total shareholder equity | $55.56 | $77.5 | $130.45 | $254.24 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $15.84 | $14.29 | $16.01 | $17.01 |
| Cost of revenue | $7.04 | $6.36 | $7.09 | $7.09 |
| Gross Profit | $8.8 | $7.93 | $8.92 | $9.92 |
| Operating activities | ||||
| Research & development | $0.77 | $0.73 | $0.92 | |
| Selling, general & administrative | $23.9 | $16.31 | $15.63 | $17.51 |
| Total operating expenses | $26.25 | $26.72 | $24.61 | |
| Operating income | -$9.8 | -$11.96 | -$10.71 | -$7.6 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.53 | |||
| Interest expense | ||||
| Net income | ||||
| Net income | -$8.58 | -$15.14 | $2.84 | -$2.91 |
| Income (for common shares) | -$15.14 | $2.84 | -$2.91 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $63.16 | $74.14 | $96.09 | $95.23 |
| Cost of revenue | $27.59 | $54.73 | $48.56 | $42.94 |
| Gross Profit | $35.57 | $19.41 | $47.53 | $52.29 |
| Operating activities | ||||
| Research & development | $2.96 | $3.44 | $5.5 | $5.95 |
| Selling, general & administrative | $69.92 | $62.22 | $83.04 | $88.11 |
| Total operating expenses | $103.22 | $124.79 | $145.15 | $142.67 |
| Operating income | -$50.65 | -$49.06 | -$47.45 | |
| Income from continuing operations | ||||
| EBIT | -$49.06 | -$47.45 | ||
| Income tax expense | $0.53 | $0.09 | $0.14 | -$8.01 |
| Interest expense | ||||
| Net income | ||||
| Net income | -$23.8 | -$59.31 | -$137.72 | -$30.68 |
| Income (for common shares) | -$59.31 | -$137.72 | -$30.68 | |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$8.58 | -$15.14 | $2.84 | -$2.91 |
| Operating activities | ||||
| Depreciation | $3.65 | $3.74 | $3.98 | $3.79 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$2.54 | -$7.84 | $1.06 | -$6.07 |
| Investing activities | ||||
| Capital expenditures | -$0.68 | -$2.83 | -$0.19 | |
| Investments | ||||
| Total cash flows from investing | -$0.61 | -$2.74 | -$0.11 | -$0.04 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$0.05 | -$0.13 | -$0.01 | -$0.07 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$3.2 | -$10.71 | $0.95 | -$6.18 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | -$23.8 | -$59.31 | -$137.72 | -$30.68 |
| Operating activities | ||||
| Depreciation | $7.74 | $11.02 | $6.85 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$15.39 | -$5.32 | -$29.56 | -$52.03 |
| Investing activities | ||||
| Capital expenditures | -$3.69 | -$0.27 | -$4.92 | -$28.26 |
| Investments | ||||
| Total cash flows from investing | -$3.51 | $0.4 | -$11.79 | -$19.16 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $8.29 | |||
| Net borrowings | $52.76 | |||
| Total cash flows from financing | -$0.25 | $52.39 | $8.04 | $55.44 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$19.14 | $47.47 | -$33.31 | -$15.75 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $63.15M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$23.79M |
| Revenue Q/Q | -16.06% |
| Revenue Y/Y | -14.83% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | -14.22% |
| ROE | -34.91% |
| Debt/Equity | 1.75 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.31 |
| Quick ratio | 2.39 |